Sympathetic excitotoxicity in sepsis: Pro-inflammatory priming of macrophages by norepinephrine

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 1, 2005, Pages 2217-2229

  Miksa, Michael ^a   Wu, Rongqian ^a   Zhou, Mian ^a   Wang, Ping ^a,b,c  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c North Shore LIJ Health System ^*  (United States)

Author keywords

Alpha2A Adrenoceptor; Ghrelin; Inflammation; Kupffer cells; Macrophages; Norepinephrine; Review; Sepsis; Sympathetic Nervous System

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENALIN; ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; CATECHOLAMINE; CHOLINERGIC RECEPTOR; GHRELIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; NORADRENALIN; PEPTIDE; RECEPTOR BLOCKING AGENT;

ADRENERGIC SYSTEM; ANTIINFLAMMATORY ACTIVITY; AUTONOMIC NERVOUS SYSTEM; BARK; BRAIN; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CYTOKINE RELEASE; EGO; EXCITOTOXICITY; HISTORY OF MEDICINE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INTESTINE; INTESTINE INNERVATION; KUPFFER CELL; MACROPHAGE; MODULATION; MONONUCLEAR CELL; NERVE; NERVOUS SYSTEM; NORADRENERGIC SYSTEM; REFLEX; REVIEW; SEPSIS; STIMULATION; SYMPATHETIC TONE; VAGUS NERVE;

EID: 21344441265     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1691     Document Type: Review

References (94)

1. Martin, G. S., D. M. Mannino, S. Eaton & M. Moss: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med, 348, 1546-54 (2003)
2. Poeze, M., G. Ramsay, H. Gerlach, F. Rubulotta & M. Levy: An international sepsis survey: a study of doctors' knowledge and perception about sepsis. Crit Care, 8, R409-13 (2004)
3. Spronk, P. E., D. F. Zandstra & C. Ince: Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care, 8, 462-8 (2004)
4. Wang, H., C. J. Czura & K. J. Tracey: Lipid unites disparate syndromes of sepsis. Nat Med, 10, 124-5 (2004)
5. Riedemann, N. C., R. F. Guo & P. A. Ward: Novel strategies for the treatment of sepsis. Nat Med, 9, 517-24 (2003)
6. Mannaioni, P. F., L. Zilletti, A. Guidotti & A. Giotti: Effects of Adrenotropic Drugs on the Release of Histamine in the Anaphylactic Reaction of the Isolated Guinea Pig Heart. Life Sci, 11, 347-50 (1964)
7. Elenkov, I. J., R. L. Wilder, G. P. Chrousos & E. S. Vizi: The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev, 52, 595-638 (2000)
8. Vizi, E. S. & I. J. Elenkov: Nonsynaptic noradrenaline release in neuro-immune responses. Acta Biol Hung, 53, 229-44 (2002)
9. Borovikova, L. V., S. Ivanova, M. Zhang, H. Yang, G. I. Botchkina, L. R. Watkins, H. Wang, N. Abumrad, J. W. Eaton & K. J. Tracey: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 405, 458-62 (2000)
10. Wang, H., M. Yu, M. Ochani, C. A. Amella, M. Tanovic, S. Susarla, J. H. Li, H. Yang, L. Ulloa, Y. Al-Abed, C. J. Czura & K. J. Tracey: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature, 421, 384-8 (2003)
11. Tracey, K. J.: The inflammatory reflex. Nature, 420, 853-9 (2002)
12. Echtenacher, B., M. A. Freudenberg, R. S. Jack & D. N. Mannel: Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun, 69, 7271-6 (2001)
13. Meyer, T. A., J. Wang, G. M. Tiao, C. K. Ogle, J. E. Fischer & P. O. Hasselgren: Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery, 118, 336-42 (1995)
14. Wang, P., T. J. Wood, Z. F. Ba & I. H. Chaudry: Pentoxifylline maintains vascular endothelial cell function during hyperdynamic and hypodynamic sepsis. Surgery, 120, 367-73 (1996)
15. Casey, L. C.: Immunologic response to infection and its role in septic shock. Crit Care Clin, 16, 193-213 (2000)
16. Falciola, L., F. Spada, S. Calogero, G. Langst, R. Voit, I. Grummt & M. E. Bianchi: High mobility group 1 protein is not stably associated with the chromosomes of somatic cells. J Cell Biol, 137, 19-26 (1997)
17. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K. R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P. E. Molina, N. N. Abumrad, A. Sama & K. J. Tracey: HMG-1 as a late mediator of endotoxin lethality in mice. Science, 285, 248-51 (1999)
18. Andersson, U., H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang & K. J. Tracey: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 192, 565-70 (2000)
19. Dallaire, F., N. Quellet, Y. Bergeron, V. Turmel, M. C. Gauthier, M. Simard & M. G. Bergeron: Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J Infect Dis, 184, 292-300 (2001)
20. van der Poll, T., C. V. Keogh, W. A. Buurman & S. F. Lowry: Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med, 155, 603-8 (1997)
21. Moore, T. A., H. Y. Lau, A. L. Cogen, C. L. Monteleon & T. J. Standiford: Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury. Shock, 20, 309-15 (2003)
22. Tracey, K. J., S. F. Lowry, T. J. Fahey, 3rd, J. D. Albert, Y. Fong, D. Hesse, B. Beutler, K. R. Manogue, S. Calvano, H. Wei & et al.: Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet, 164, 415-22 (1987)
23. Tracey, K. J. & A. Cerami: Tumor necrosis factor: an updated review of its biology. Crit Care Med, 21, S415-22 (1993)
24. Bianchi, M., O. Bloom, T. Raabe, P. S. Cohen, J. Chesney, B. Sherry, H. Schmidtmayerova, T. Calandra, X. Zhang, M. Bukrinsky, P. Ulrich, A. Cerami & K. J. Tracey: Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med, 183, 927-36 (1996)
25. Yang, H., M. Ochani, J. Li, X. Qiang, M. Tanovic, H. E. Harris, S. M. Susarla, L. Ulloa, H. Wang, R. DiRaimo, C. J. Czura, J. Roth, H. S. Warren, M. P. Fink, M. J. Fenton, U. Andersson & K. J. Tracey: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A, 101, 296-301 (2004)
26. Laborit, H.: On the mechanism of activation of the hypothalamo-pituitary- adrenal reaction to changes in the environment (the 'alarm reaction'). Resuscitation, 5, 19-30 (1976)
27. Seyle, H.: Thymus and adrenals in the response of the organism to injuries and intoxications. Br J Exp Pathol, 17, 234-238 (1936)
28. Besedovsky, H., A. del Rey, E. Sorkin & C. A. Dinarello: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science, 233, 652-4 (1986)
29. Wapnir, R. A. & S. Teichberg: Regulation mechanisms of intestinal secretion: implications in nutrient absorption. J Nutr Biochem, 13, 190-199 (2002)
30. Breder, C. D., C. A. Dinarello & C. B. Saper: Interleukin-1 immunoreactive innervation of the human hypothalamus. Science, 240, 321-4 (1988)
31. Porter, M. H., B. J. Hrupka, W. Langhans & G. J. Schwartz: Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP. Am J Physiol, 275, R384-9 (1998)
32. Steinman, L.: Elaborate interactions between the immune and nervous systems. Nat Immunol, 5, 575-81 (2004)
33. Lundberg, J. M., A. Rudehill & A. Sollevi: Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen. Eur J Pharmacol, 163, 103-13 (1989)
34. Bergmann, M. & T. Sautner: Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr, 114, 752-61 (2002)
35. Zhou, M., H. Hank Simms & P. Wang: Increased gut-derived norepinephrine release in sepsis: up-regulation of intestinal tyrosine hydroxylase. Biochim Biophys Acta, 1689, 212-8 (2004)
36. Hahn, P. Y., P. Wang, S. M. Tait, Z. F. Ba, S. S. Reich & I. H. Chaudry: Sustained elevation in circulating catecholamine levels during polymicrobial sepsis. Shock, 4, 269-73 (1995)
37. Yang, S., D. J. Koo, M. Zhou, I. H. Chaudry & P. Wang: Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am J Physiol Gastrointest Liver Physiol, 279, G1274-81 (2000)
38. Allen, L.-A. H., C. Yang & J. E. Pessin: Rate and extent of phagocytosis in macrophages lacking vamp3. J Leukoc Biol, 72, 217-221 (2002)
39. Pagan, J. K., F. G. Wylie, S. Joseph, C. Widberg, N. J. Bryant, D. E. James & J. L. Stow: The t-SNARE syntaxin 4 is regulated during macrophage activation to function in membrane traffic and cytokine secretion. Curr Biol, 13, 156-60 (2003)
40. Prekeris, R., J. Klumperman & R. H. Scheller: Syntaxin 11 is an atypical SNARE abundant in the immune system. Eur J Cell Biol, 79, 771-80 (2000)
41. Shukla, A., L. Berglund, L. P. Nielsen, S. Nielsen, H. J. Hoffmann & R. Dahl: Regulated exocytosis in immune function: are SNARE-proteins involved? Respir Med, 94, 10-7 (2000)
42. Hackam, D. J., O. D. Rotstein, M. K. Bennett, A. Klip, S. Grinstein & M. F. Manolson: Characterization and subcellular localization of target membrane soluble NSF attachment protein receptors (t-SNAREs) in macrophages. Syntaxins 2, 3, and 4 are present on phagosomal membranes. J Immunol, 156, 4377-83 (1996)
43. Kushima, Y., T. Fujiwara, T. Morimoto & K. Akagawa: Involvement of HPC-1/syntaxin-1A antigen in transmitter release from PC12h cells. Biochem Biophys Res Commun, 212, 97-103 (1995)
44. Ashton, A. C. & J. O. Dolly: A late phase of exocytosis from synaptosomes induced by elevated [Ca2+]i is not blocked by Clostridial neurotoxins. J Neurochem, 74, 1979-88 (2000)
45. Baltazar, G., A. P. Carvalho & E. P. Duarte: Differential expression of syntaxin 1A and 1B by noradrenergic and adrenergic chromaffin cells. Neurochem Res, 28, 1453-7 (2003)
46. Sung, U., S. Apparsundaram, A. Galli, K. M. Kahlig, V. Savchenko, S. Schroeter, M. W. Quick & R. D. Blakely: A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci, 23, 1697-709 (2003)
47. Scales, S. J., B. A. Hesser, E. S. Masuda & R. H. Scheller: Amisyn, a novel syntaxin-binding protein that may regulate SNARE complex assembly. J Biol Chem, 277, 28271-9 (2002)
48. Masson, J., C. Sagne, M. Hamon & S. El Mestikawy: Neurotransmitter transporters in the central nervous system. Pharmacol Rev, 51, 439-64 (1999)
49. Yang, S., M. Zhou, I. H. Chaudry & P. Wang: Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors. Am J Physiol Gastrointest Liver Physiol, 281, G1014-21 (2001)
50. Zhou, M., S. Yang, D. J. Koo, D. A. Oman, I. H. Chaudry & P. Wang: The role of Kupffer cell alpha (2)-adrenoceptors in norepinephrine-induced TNF-alpha production. Biochim Biophys Acta, 1537, 49-57 (2001)
51. Zhou, M., P. Das, H. H. Simms & P. Wang: Gut-derived Norepinephrine plays an important role in upregulating IL-1β and IL-10 (In Pess). BBA (2005)
52. Spengler, R. N., R. M. Allen, D. G. Remick, R. M. Strieter & S. L. Kunkel: Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol, 145, 1430-4 (1990)
53. Hu, X. X., E. A. Goldmuntz & C. F. Brosnan: The effect of norepinephrine on endotoxin-mediated macrophage activation. J Neuroimmunol, 31, 35-42 (1991)
54. Miller, L. E., J. Grifka, J. Scholmerich & R. H. Straub: Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J Rheumatol, 29, 427-35 (2002)
55. Elenkov, I. J., D. A. Papanicolaou, R. L. Wilder & G. P. Chrousos: Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians, 108, 374-81 (1996)
56. Hasko, G., C. Szabo, Z. H. Nemeth, A. L. Salzman & E. S. Vizi: Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J Neuroimmunol, 88, 57-61 (1998)
57. Severn, A., N. T. Rapson, C. A. Hunter & F. Y. Liew: Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol, 148, 3441-5 (1992)
58. 2A-adrenoceptor (AR) plays an important role in TNF-α release in sepsis. Shock, 21, 30 (2004)
59. Das, P., R. Wu, W. Dong, D. Yang & P. Wang: A novel approach to inhibit inflammatory responses in sepsis: modulation of the sympathetic nervous system (in press). Shock (2005)
60. Roy, B. & U. Rai: Dual mode of catecholamine action on splenic macrophage phagocytosis in wall lizard, Hemidactylus flaviviridis. Gen Comp Endocrinol, 136, 180-91 (2004)
61. Kojima, M., H. Hosoda, Y. Date, M. Nakazato, H. Matsuo & K. Kangawa: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-60 (1999)
62. Date, Y., N. Murakami, M. Kojima, T. Kuroiwa, S. Matsukura, K. Kangawa & M. Nakazato: Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun, 275, 477-80 (2000)
63. Wu, J. T. & J. G. Kral: Ghrelin: integrative neuroendocrine peptide in health and disease. Ann Surg, 239, 464-74 (2004)
64. van der Lely, A. J., M. Tschop, M. L. Heiman & E. Ghigo: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev, 25, 426-57 (2004)
65. Cowley, M. A. & K. L. Grove: Ghrelin - satisfying a hunger for the mechanism. Endocrinology, 145, 2604-6 (2004)
66. Tschop, M., D. L. Smiley & M. L. Heiman: Ghrelin induces adiposity in rodents. Nature, 407, 908-13 (2000)
67. Date, Y., M. Kojima, H. Hosoda, A. Sawaguchi, M. S. Mondal, T. Suganuma, S. Matsukura, K. Kangawa & M. Nakazato: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology, 141, 4255-61 (2000)
68. Sakata, I., T. Tanaka, M. Matsubara, M. Yamazaki, S. Tani, Y. Hayashi, K. Kangawa & T. Sakai: Postnatal changes in ghrelin mRNA expression and in ghrelin-producing cells in the rat stomach. J Endocrinol, 174, 463-71 (2002)
69. Hewson, A. K. & S. L. Dickson: Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol, 12, 1047-9 (2000)
70. Matsumura, K., T. Tsuchihashi, K. Fujii, I. Abe & M. Iida: Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension, 40, 694-9 (2002)
71. Nagaya, N., M. Kojima, M. Uematsu, M. Yamagishi, H. Hosoda, H. Oya, Y. Hayashi & K. Kangawa: Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol, 280, R1483-7 (2001)
72. Lin, Y., K. Matsumura, M. Fukuhara, S. Kagiyama, K. Fujii & M. Iida: Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension, 43, 977-82 (2004)
73. Yasuda, T., T. Masaki, T. Kakuma & H. Yoshimatsu: Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci Lett, 349, 75-8 (2003)
74. Nagaya, N., J. Moriya, Y. Yasumura, M. Uematsu, F. Ono, W. Shimizu, K. Ueno, M. Kitakaze, K. Miyatake & K. Kangawa: Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation, 110, 3674-9 (2004)
75. Wu, R., M. Zhou, X. Cui, H. H. Simms & P. Wang: Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am J Physiol Heart Circ Physiol, 287, H1296-302 (2004)
76. Hataya, Y., T. Akamizu, H. Hosoda, N. Kanamoto, K. Moriyama, K. Kangawa, K. Takaya & K. Nakao: Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology, 144, 5365-71 (2003)
77. Basa, N. R., L. Wang, J. R. Arteaga, D. Heber, E. H. Livingston & Y. Tache: Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats. Neurosci Lett, 343, 25-8 (2003)
78. Wu, R., W. Dong, H. Simms & P. Wang: Ghrelin downregulates TNF-alpha in sepsis via the activation of the vagus nerve. Surg Infect, (in press), (2005)
79. Kalra, S. P. & P. S. Kalra: Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine, 22, 49-56 (2003)
80. Zhang, Z. H. & R. B. Felder: Melanocortin receptors mediate the excitatory effects of blood-borne murine leptin on hypothalamic paraventricular neurons in rat. Am J Physiol Regul Integr Comp Physiol, 286, R303-10 (2004)
81. Li, Y. F., K. G. Cornish & K. P. Patel: Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circ Res, 93, 990-7 (2003)
82. Pin, J. P. & R. Duvoisin: The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 34, 1-26 (1995)
83. Chen, Q. H., J. R. Haywood & G. M. Toney: Sympathoexcitation by PVN-injected bicuculline requires activation of excitatory amino acid receptors. Hypertension, 42, 725-31 (2003)
84. Kalsbeek, A., S. La Fleur, C. Van Heijningen & R. M. Buijs: Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J Neurosci, 24, 7604-13 (2004)
85. Eggers, V., A. Schilling, W. J. Kox & C. Spies: [Septic encephalopathy. Diagnosis und therapy]. Anaesthesist, 52, 294-303 (2003)
86. Ahboucha, S., P. Desjardins, N. Chatauret, G. Pomier-Layrargues & R. F. Butterworth: Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy. Neurochem Int, 43, 551-6 (2003)
87. Kadoi, Y. & S. Saito: An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit Care Med, 24, 298-305 (1996)
88. Komatsubara, T., Y. Kadoi & S. Saito: Augmented sensitivity to benzodiazepine in septic shock rats. Can J Anaesth, 42, 937-43 (1995)
89. Olney, J. W.: Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science, 164, 719-21 (1969)
90. Prass, K., C. Meisel, C. Hoflich, J. Braun, E. Halle, T. Wolf, K. Ruscher, I. V. Victorov, J. Priller, U. Dirnagl, H. D. Volk & A. Meisel: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med, 198, 725-36 (2003)
91. Freestone, P. P., P. H. Williams, R. D. Haigh, A. F. Maggs, C. P. Neal & M. Lyte: Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock, 18, 465-70 (2002)
92. Lyte, M., P. P. Freestone, C. P. Neal, B. A. Olson, R. D. Haigh, R. Bayston & P. H. Williams: Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet, 361, 130-5 (2003)
93. Dunn, A. J., T. Ando, R. F. Brown & R. D. Berg: HPA axis activation and neurochemical responses to bacterial translocation from the gastrointestinal tract. Ann N Y Acad Sci, 992, 21-9 (2003)
94. Alverdy, J., C. Holbrook, F. Rocha, L. Seiden, R. L. Wu, M. Musch, E. Chang, D. Ohman & S. Suh: Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg, 232, 480-9 (2000)